The report covers forecast and analysis for the in vivo toxicology market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the in vivo toxicology market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the in vivo toxicology market on a global as well as regional level.
In order to give the users of this report a comprehensive view of the in vivo toxicology market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the in vivo toxicology market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the in vivo toxicology market on the global and regional basis.
The study provides a decisive view of the in vivo toxicology market by segmenting the market based on product, testing type, toxicity endpoints, and regions. The segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. The product segment is segmented into instruments, animal models, and reagents & kits. Animal models segment held the maximum share of the product segment owing to rise in the development of genetically modified animals. Based on the testing type, in vivo toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on toxicity endpoints, in vivo toxicology market is segmented into systemic toxicity, immunotoxicity, and DART.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further division into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for in vivo toxicology based on the individual segment in all the regions and countries.
The report also includes detailed profiles of end players such as Danaher, Charles River, Thermo Fisher, The Jackson Laboratory, and Covance, among others.
This report segments the global in vivo toxicology market as follows:
Global In Vivo Toxicology Market: By Product
- Instruments
- Animal models
- Reagents & Kits
Global In Vivo Toxicology Market: By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
Global In Vivo Toxicology Market: By Toxicity Endpoints
- Systemic Toxicity
- Immunotoxicity
- DART
Global In Vivo Toxicology Market: By Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Table of Contents
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global In Vivo Toxicology market, 2017 - 2024 (USD Million)
- 2.2. Global In Vivo Toxicology market : Snapshot
- Chapter 3. In Vivo Toxicology- Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global in vivo toxicology market drivers: Impact analysis
- 3.2.2. Rise in pharmaceutical research and development activities
- 3.2.3. Development of exclusive in vivo toxicology tests
- 3.3. Market restraints
- 3.3.1. Drawbacks of animal testing
- 3.3.2. Rising demand to develop and undertake substitute animal testing methods
- 3.4. Opportunities
- 3.4.1. Increasing focus on development of personalized medicine
- 3.4.2. Increasing demand for humanized animal models
- 3.5. Porter's five forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. Threat from new entrants
- 3.5.4. Threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by product segment
- 3.6.2. Market attractiveness analysis, by testing type segment
- 3.6.3. Market attractiveness analysis, by toxicity endpoints segment
- Chapter 4. Global In Vivo Toxicology Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global in vivo toxicology market: company market share, 2017
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development, Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global In Vivo Toxicology Market - Product Segment Analysis
- 5.1. Global in vivo toxicology market: Product overview
- 5.1.1. Global in vivo toxicology market revenue share, by Product, 2017 and 2024
- 5.2. Instruments
- 5.2.1. Global in vivo toxicology market for Instruments, 2017 - 2024 (USD Million)
- 5.3. Animal models
- 5.3.1. Global in vivo toxicology market for Animal models, 2017 - 2024 (USD Million)
- 5.4. Reagents & Kits
- 5.4.1. Global in vivo toxicology market for Reagents & Kits, 2017 - 2024 (USD Million)
- 5.1. Global in vivo toxicology market: Product overview
- Chapter 6. Global In Vivo Toxicology Market - Testing Type Segment Analysis
- 6.1. Global in vivo toxicology market: Testing Type overview
- 6.1.1. Global in vivo toxicology market revenue share, by Testing Type, 2017 and 2024
- 6.2. Chronic Toxicity Testing
- 6.2.1. Global in vivo toxicology market for Chronic Toxicity Testing, 2017 - 2024 (USD Million)
- 6.3. Sub-chronic Toxicity Testing
- 6.3.1. Global in vivo toxicology market for Sub-chronic Toxicity Testing, 2017 - 2024 (USD Million)
- 6.4. Sub-acute Toxicity Testing
- 6.4.1. Global in vivo toxicology market for Sub-acute Toxicity Testing, 2017 - 2024 (USD Million)
- 6.5. Acute Toxicity Testing
- 6.5.1. Global in vivo toxicology market for Acute Toxicity Testing, 2017 - 2024 (USD Million)
- 6.1. Global in vivo toxicology market: Testing Type overview
- Chapter 7. Global In Vivo Toxicology Market - Toxicity Endpoints Segment Analysis
- 7.1. Global in vivo toxicology market: Toxicity Endpoints overview
- 7.1.1. Global in vivo toxicology market revenue share, by Toxicity Endpoints, 2017 and 2024
- 7.2. Systemic Toxicity
- 7.2.1. Global in vivo toxicology market for Systemic Toxicity, 2017 - 2024 (USD Million)
- 7.3. Immunotoxicity
- 7.3.1. Global in vivo toxicology market for Immunotoxicity, 2017 - 2024 (USD Million)
- 7.4. DART
- 7.4.1. Global in vivo toxicology market for DART, 2017 - 2024 (USD Million)
- 7.1. Global in vivo toxicology market: Toxicity Endpoints overview
- Chapter 8. Global In Vivo Toxicology Market - Regional Segment Analysis
- 8.1. Global in vivo toxicology market: Regional overview
- 8.1.1. Global in vivo toxicology market revenue share, by region, 2017 and 2024
- 8.2. North America
- 8.2.1. North America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.2.2. North America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.2.3. North America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.2.4. U.S.
- 8.2.4.1. U.S. in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.2.4.2. U.S. in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.2.4.3. U.S. in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.2.5. Canada
- 8.2.5.1. Canada in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.2.5.2. Canada in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.2.5.3. Canada in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.2.6.2. Rest of North America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.2.6.3. Rest of North America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3. Europe
- 8.3.1. Europe in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.2. Europe in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.3. Europe in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.4. Germany
- 8.3.4.1. Germany in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.4.2. Germany in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.4.3. Germany in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.5. U.K.
- 8.3.5.1. U.K. in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.5.2. U.K. in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.5.3. U.K. in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.6. France
- 8.3.6.1. France in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.6.2. France in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.6.3. France in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.7. Italy
- 8.3.7.1. Italy in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.7.2. Italy in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.7.3. Italy in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.8. Spain
- 8.3.8.1. Spain in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.8.2. Spain in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.8.3. Spain in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.9. Russia
- 8.3.9.1. Russia in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.9.2. Russia in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.9.3. Russia in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.3.10. Rest of Europe
- 8.3.10.1. Rest of Europe in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.3.10.2. Rest of Europe in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.3.10.3. Rest of Europe in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.4.2. Asia Pacific in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.4.3. Asia Pacific in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.4.4. China
- 8.4.4.1. China in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.4.4.2. China in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.4.4.3. China in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.4.5.2. Japan in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.4.5.3. Japan in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.4.6. India
- 8.4.6.1. India in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.4.6.2. India in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.4.6.3. India in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.4.7. Australia
- 8.4.7.1. Australia in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.4.7.2. Australia in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.4.7.3. Australia in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.4.8.2. Rest of Asia Pacific in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.4.8.3. Rest of Asia Pacific in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.5.2. Latin America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.5.3. Latin America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.5.4.2. Brazil in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.5.4.3. Brazil in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.5.5. Mexico
- 8.5.5.1. Mexico in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.5.5.2. Mexico in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.5.5.3. Mexico in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.5.6. Argentina
- 8.5.6.1. Argentina in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.5.6.2. Argentina in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.5.6.3. Argentina in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.5.7. Rest of Latin America
- 8.5.7.1. Rest of Latin America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.5.7.2. Rest of Latin America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.5.7.3. Rest of Latin America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.6.2. Middle East and Africa in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.6.3. Middle East and Africa in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.6.4. Saudi Arabia
- 8.6.4.1. Saudi Arabia in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.6.4.2. Saudi Arabia in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.6.4.3. Saudi Arabia in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.6.5. UAE
- 8.6.5.1. UAE in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.6.5.2. UAE in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.6.5.3. UAE in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.6.6. South Africa
- 8.6.6.1. South Africa in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.6.6.2. South Africa in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.6.6.3. South Africa in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.6.7. Qatar
- 8.6.7.1. Qatar in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.6.7.2. Qatar in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.6.7.3. Qatar in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.6.8. Rest of Middle East and Africa
- 8.6.8.1. Rest of Middle East and Africa in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
- 8.6.8.2. Rest of Middle East and Africa in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
- 8.6.8.3. Rest of Middle East and Africa in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
- 8.1. Global in vivo toxicology market: Regional overview
- Chapter 9. Company Profile
- 9.1. Danaher
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Therapy portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Charles River
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Therapy portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Thermo Fisher
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Therapy portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. The Jackson Laboratory
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Therapy portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Covance
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Therapy portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.1. Danaher
